SKYE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,910,712.67

Skye Bioscience Insider Trading History Chart

Skye Bioscience Share Price & Price History

^$1.41

▲ +0.07 (5.22%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Skye Bioscience Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Kaitlyn Arsenault	CFO	Sell	43,206	$4.99	$215,597.94	166,342
11/18/2024	Paul A Grayson	Director	Sell	86,244	$4.99	$430,357.56	259,701
11/18/2024	Punit Dhillon	CEO	Sell	82,546	$4.99	$411,904.54	329,823
11/18/2024	Tuan Tu Diep	Insider	Sell	19,489	$4.99	$97,250.11	82,259
11/15/2024	Kaitlyn Arsenault	CFO	Sell	190	$5.55	$1,054.50	209,548
11/15/2024	Paul A Grayson	Director	Sell	307	$5.55	$1,703.85	345,945
11/15/2024	Punit Dhillon	CEO	Sell	364	$5.55	$2,020.20	412,369
11/15/2024	Tuan Tu Diep	Insider	Sell	85	$5.55	$471.75	101,748
9/13/2024	Andrew J Schwab	Director	Sell	13,837	$6.06	$83,852.22	66,277
9/11/2024	Andrew J Schwab	Director	Sell	252,500	$6.60	$1,666,500.00	66,356

See Full Table

SEC Filings (Institutional Ownership Changes) for Skye Bioscience (NASDAQ:SKYE)

21.09% of Skye Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Skye Bioscience Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Squarepoint Ops LLC	13,546	$38K	0.0%	N/A	0.045%
2/17/2025	Two Sigma Advisers LP	11,200	$32K	0.0%	N/A	0.037%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	326,241	$0.92M	0.0%	-5.3%	1.075%
2/17/2025	Ensign Peak Advisors Inc	767,287	$2.17M	0.0%	-14.7%	2.529%
2/17/2025	Deutsche Bank AG	40,835	$0.12M	0.0%	+365.0%	0.135%
2/17/2025	Bridgeway Capital Management LLC	72,000	$0.20M	0.0%	+26.3%	0.237%
2/17/2025	Braidwell LP	825,732	$2.34M	0.1%	N/A	2.722%
2/17/2025	Baker BROS. Advisors LP	1,450,638	$4.11M	0.0%	+1.1%	4.781%
2/17/2025	Bank of America Corp DE	39,257	$0.11M	0.0%	+37.4%	0.129%
2/17/2025	BNP Paribas Financial Markets	31,637	$90K	0.0%	-33.3%	0.104%
2/17/2025	Alyeska Investment Group L.P.	456,163	$1.29M	0.0%	-17.7%	1.504%
2/14/2025	Jane Street Group LLC	36,057	$0.10M	0.0%	+195.5%	0.119%
2/14/2025	Schonfeld Strategic Advisors LLC	1,422,741	$4.03M	0.0%	+48.3%	4.689%
2/14/2025	AdvisorShares Investments LLC	88,391	$0.25M	0.0%	-23.1%	0.291%
2/14/2025	Northern Trust Corp	135,712	$0.38M	0.0%	-3.7%	0.447%
2/14/2025	Altium Capital Management LLC	1,139,000	$3.22M	0.9%	-13.4%	3.754%
2/13/2025	Barclays PLC	69,620	$0.20M	0.0%	+20.3%	0.229%
2/13/2025	Wells Fargo & Company MN	11,199	$32K	0.0%	+49.0%	0.037%
2/12/2025	Geode Capital Management LLC	405,694	$1.15M	0.0%	+5.2%	1.337%
2/11/2025	Virtu Financial LLC	10,142	$29K	0.0%	N/A	0.033%
2/11/2025	Platinum Investment Management Ltd.	434,046	$1.23M	0.1%	-10.5%	1.431%
2/6/2025	Charles Schwab Investment Management Inc.	62,363	$0.18M	0.0%	+20.7%	0.206%
1/1/2025	JPMorgan Chase & Co.	11,362	$44K	0.0%	-24.1%	0.037%
11/19/2024	Barclays PLC	57,889	$0.23M	0.0%	+36.7%	0.191%
11/16/2024	Geode Capital Management LLC	385,793	$1.51M	0.0%	+4.2%	1.272%
11/15/2024	Barclays PLC	57,889	$0.23M	0.0%	+36.7%	0.191%
11/15/2024	Jane Street Group LLC	12,200	$48K	0.0%	N/A	0.040%
11/15/2024	Sphera Funds Management LTD.	1,563,522	$6.11M	1.0%	+20.4%	5.153%
11/15/2024	State Street Corp	354,205	$1.39M	0.0%	+7.0%	1.167%
11/15/2024	Point72 Asset Management L.P.	416,424	$1.63M	0.0%	-25.6%	1.373%
11/15/2024	Baker BROS. Advisors LP	1,434,634	$5.61M	0.1%	+186.9%	4.729%
11/13/2024	BNP Paribas Financial Markets	47,417	$0.19M	0.0%	+71.1%	0.156%
9/16/2024	Point72 DIFC Ltd	6,000	$48K	0.0%	N/A	0.021%
9/16/2024	Cubist Systematic Strategies LLC	3,762	$30K	0.0%	N/A	0.013%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	27,768	$0.22M	0.0%	N/A	0.099%
8/19/2024	Point72 Asset Management L.P.	560,000	$4.49M	0.0%	N/A	1.995%
8/16/2024	Perceptive Advisors LLC	500,000	$4.01M	0.1%	N/A	1.781%
8/16/2024	Driehaus Capital Management LLC	650,758	$5.21M	0.0%	N/A	2.319%
8/15/2024	CVI Holdings LLC	679,739	$5.45M	4.9%	N/A	2.422%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	27,768	$0.22M	0.0%	N/A	0.099%
8/14/2024	Cubist Systematic Strategies LLC	3,762	$30K	0.0%	N/A	0.013%
8/14/2024	Point72 DIFC Ltd	6,000	$48K	0.0%	N/A	0.021%
8/14/2024	Logos Global Management LP	1,301,518	$10.43M	0.8%	N/A	4.637%
8/8/2024	AdvisorShares Investments LLC	26,000	$0.21M	0.0%	N/A	0.093%
8/1/2024	Rhumbline Advisers	19,754	$0.16M	0.0%	N/A	0.070%
7/26/2024	Bank of New York Mellon Corp	58,778	$0.47M	0.0%	N/A	0.209%

Data available starting January 2016

See Full Table

Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

Today's Range

Now: $1.41

$1.30

$1.41

50 Day Range

MA: $1.84

$1.20

$2.80

52 Week Range

Now: $1.41

$1.14

$17.65

Volume

140,400 shs

Average Volume

226,307 shs

Market Capitalization

$43.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Skye Bioscience?: Skye Bioscience's top insider shareholders include:
Punit Dhillon (CEO)
Paul A Grayson (Director)
Kaitlyn Arsenault (CFO)
Tuan Tu Diep (Insider)
Andrew J Schwab (Director)
Learn More about top insider investors at Skye Bioscience.